Abstract | OBJECTIVE: METHODS: Twenty-two patients with low-grade endometrial stromal sarcomas were reviewed to determine whether they were exposed to exogenous or endogenous estrogen and/or progestins following their diagnosis and whether exposure to these hormones might have influenced their prognosis. Estrogen receptor (ER) alpha and beta and progestin receptor (PR) status were analyzed from paraffin-embedded tissue by immunohistochemistry and ER mRNA was measured in fresh tissue by reverse transcription polymerase chain reaction (RT-PCR). RESULTS: Ten of the twenty-two patients with low-grade endometrial stromal sarcomas developed recurrent disease. Four of five patients (80%) who received estrogen replacement therapy (ERT) recurred. Four of eight patients (50%) with retained ovaries recurred. Eight of the ten specimens available for analysis were positive for ERalpha, none were positive for ERbeta, and 9 of 10 were positive for PR. Four of thirteen patients who received progestins as adjuvant therapy recurred, compared with 6 of 9 patients who did not receive progestins (31% vs 67%). Eight recurrences were treated with progestin therapy and 7 (88%) of them had either stable disease (3/8, 38%) or complete response (4/8, 50%). CONCLUSIONS:
|
Authors | Micheline C Chu, Gil Mor, Chungyun Lim, Wenxin Zheng, Vinita Parkash, Peter E Schwartz |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 90
Issue 1
Pg. 170-6
(Jul 2003)
ISSN: 0090-8258 [Print] United States |
PMID | 12821359
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Estrogen Receptor alpha
- Estrogen Receptor beta
- RNA, Messenger
- Receptors, Estrogen
- Receptors, Progesterone
|
Topics |
- Adult
- Aged
- Endometrial Neoplasms
(chemically induced, metabolism, pathology, surgery)
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Estrogen Replacement Therapy
(adverse effects)
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
(chemically induced, pathology)
- Neoplasm Staging
- RNA, Messenger
(biosynthesis, genetics)
- Receptors, Estrogen
(biosynthesis, genetics)
- Receptors, Progesterone
(biosynthesis, genetics)
- Sarcoma, Endometrial Stromal
(chemically induced, metabolism, pathology, surgery)
|